These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 29249809)
1. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy. Vagnozzi AN; Giannopoulos PF; Praticò D Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809 [TBL] [Abstract][Full Text] [Related]
2. Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice. Vagnozzi AN; Giannopoulos PF; Praticò D Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29106033 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of 5-Lipoxygenase Worsens the Phenotype of a Mouse Model of Tauopathy. Giannopoulos PF; Praticò D Mol Neurobiol; 2018 Jul; 55(7):5926-5936. PubMed ID: 29128902 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy. Giannopoulos PF; Chu J; Sperow M; Li JG; Yu WH; Kirby LG; Abood M; Praticò D Biol Psychiatry; 2015 Nov; 78(10):693-701. PubMed ID: 25802082 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy. Sun XY; Dong QX; Zhu J; Sun X; Zhang LF; Qiu M; Yu XL; Liu RT Curr Alzheimer Res; 2019; 16(8):710-722. PubMed ID: 31368873 [TBL] [Abstract][Full Text] [Related]
6. Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice. Giannopoulos PF; Chiu J; Praticò D Aging Cell; 2018 Jun; 17(3):e12759. PubMed ID: 29607621 [TBL] [Abstract][Full Text] [Related]
7. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice. Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432 [TBL] [Abstract][Full Text] [Related]
8. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles. Chu J; Li JG; Praticò D PLoS One; 2013; 8(8):e70991. PubMed ID: 23951061 [TBL] [Abstract][Full Text] [Related]
9. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice. Joshi YB; Chu J; Praticò D Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895 [TBL] [Abstract][Full Text] [Related]
10. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy. Di Meco A; Li JG; Barrero C; Merali S; Praticò D Mol Psychiatry; 2019 Nov; 24(11):1696-1706. PubMed ID: 29728702 [TBL] [Abstract][Full Text] [Related]
11. 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease. Chu J; Giannopoulos PF; Ceballos-Diaz C; Golde TE; Praticò D Ann Neurol; 2012 Sep; 72(3):442-54. PubMed ID: 23034916 [TBL] [Abstract][Full Text] [Related]
12. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
13. The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: in vivo and in vitro evidence. Chu J; Li JG; Ceballos-Diaz C; Golde T; Praticò D Biol Psychiatry; 2013 Sep; 74(5):321-8. PubMed ID: 23352590 [TBL] [Abstract][Full Text] [Related]
14. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease. Giannopoulos PF; Chu J; Joshi YB; Sperow M; Li JG; Kirby LG; Praticò D Mol Psychiatry; 2014 Apr; 19(4):511-8. PubMed ID: 23478745 [TBL] [Abstract][Full Text] [Related]
15. Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy. Chang JK; Leso A; Subaiea GM; Lahouel A; Masoud A; Mushtaq F; Deeb R; Eid A; Dash M; Bihaqi SW; Zawia NH Curr Alzheimer Res; 2018; 15(7):655-663. PubMed ID: 29357795 [TBL] [Abstract][Full Text] [Related]
16. Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase. Joshi YB; Giannopoulos PF; Chu J; Praticò D Neurobiol Aging; 2014 May; 35(5):1024-31. PubMed ID: 24332986 [TBL] [Abstract][Full Text] [Related]
17. 5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5. Chu J; Praticò D Neurobiol Aging; 2013 Jun; 34(6):1549-54. PubMed ID: 23332172 [TBL] [Abstract][Full Text] [Related]
18. Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase. Lauretti E; Praticò D J Alzheimers Dis; 2018; 64(s1):S481-S489. PubMed ID: 29758943 [TBL] [Abstract][Full Text] [Related]
19. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy. Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341 [TBL] [Abstract][Full Text] [Related]
20. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy. Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]